Solid Biosciences (SLDB) Share-based Compensation (2017 - 2026)
Quarterly results put Share-based Compensation at $5.2 million for Q1 2026, up 54.21% from a year ago — trailing twelve months through Mar 2026 was $18.7 million (up 52.87% YoY), and the annual figure for FY2025 was $16.9 million, up 60.79%.
Solid Biosciences has reported Share-based Compensation over the past 10 years, most recently at $5.2 million for Q1 2026.
- Share-based Compensation reached $5.2 million in Q1 2026 per SLDB's latest filing, down from $6.5 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $6.5 million in Q4 2025 and bottomed at $1.5 million in Q3 2022.
- Median Share-based Compensation over the past 5 years was $2.1 million (2023), compared with a mean of $2.8 million.
- The largest annual shift saw Share-based Compensation plummeted 55.39% in 2022 before it skyrocketed 107.39% in 2025.
- Over 5 years, Share-based Compensation stood at $1.6 million in 2022, then increased by 22.12% to $1.9 million in 2023, then skyrocketed by 97.16% to $3.8 million in 2024, then skyrocketed by 70.11% to $6.5 million in 2025, then dropped by 20.74% to $5.2 million in 2026.
- Business Quant data shows Share-based Compensation for SLDB at $5.2 million in Q1 2026, $6.5 million in Q4 2025, and $3.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 892,057.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 305,000.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 166.40 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 257.40 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 70.15 Mn |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - | 5.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.15 Mn |
| Mar 31, 2026 | 5.15 Mn |
| Dec 31, 2025 | 6.50 Mn |
| Dec 31, 2025 | 6.50 Mn |
| Sep 30, 2025 | 3.93 Mn |
| Sep 30, 2025 | 3.93 Mn |
| Jun 30, 2025 | 3.15 Mn |
| Jun 30, 2025 | 3.15 Mn |
| Mar 31, 2025 | 3.34 Mn |
| Mar 31, 2025 | 3.34 Mn |
| Dec 31, 2024 | 3.82 Mn |
| Dec 31, 2024 | 3.82 Mn |
| Sep 30, 2024 | 3.00 Mn |
| Sep 30, 2024 | 3.00 Mn |
| Jun 30, 2024 | 2.09 Mn |
| Jun 30, 2024 | 2.09 Mn |
| Mar 31, 2024 | 1.61 Mn |
| Mar 31, 2024 | 1.61 Mn |
| Dec 31, 2023 | 1.94 Mn |
| Dec 31, 2023 | 1.94 Mn |
| Sep 30, 2023 | 1.63 Mn |
| Sep 30, 2023 | 1.63 Mn |
| Jun 30, 2023 | 1.94 Mn |
| Jun 30, 2023 | 1.94 Mn |
| Mar 31, 2023 | 2.12 Mn |
| Mar 31, 2023 | 2.12 Mn |
| Dec 31, 2022 | 1.59 Mn |
| Dec 31, 2022 | 1.59 Mn |
| Sep 30, 2022 | 1.52 Mn |
| Sep 30, 2022 | 1.52 Mn |
| Jun 30, 2022 | 1.81 Mn |
| Jun 30, 2022 | 1.81 Mn |
| Mar 31, 2022 | 2.61 Mn |
| Mar 31, 2022 | 2.61 Mn |
| Dec 31, 2021 | 3.42 Mn |
| Dec 31, 2021 | 3.42 Mn |
| Sep 30, 2021 | 3.42 Mn |
| Sep 30, 2021 | 3.42 Mn |
| Jun 30, 2021 | 3.64 Mn |
| Jun 30, 2021 | 3.64 Mn |
| Mar 31, 2021 | 2.91 Mn |
| Mar 31, 2021 | 2.91 Mn |
| Dec 31, 2020 | 2.52 Mn |
| Dec 31, 2020 | 2.52 Mn |
| Sep 30, 2020 | 2.76 Mn |
| Sep 30, 2020 | 2.76 Mn |
| Jun 30, 2020 | 3.24 Mn |
| Jun 30, 2020 | 3.24 Mn |
| Mar 31, 2020 | 3.10 Mn |
| Mar 31, 2020 | 3.10 Mn |
| Dec 31, 2019 | 3.40 Mn |
| Dec 31, 2019 | 3.40 Mn |
| Sep 30, 2019 | 3.39 Mn |
| Sep 30, 2019 | 3.39 Mn |
| Jun 30, 2019 | 3.91 Mn |
| Jun 30, 2019 | 3.91 Mn |
| Mar 31, 2019 | 3.50 Mn |
| Mar 31, 2019 | 3.50 Mn |
| Dec 31, 2018 | 2.03 Mn |
| Dec 31, 2018 | 2.03 Mn |
| Sep 30, 2018 | 1.80 Mn |
| Sep 30, 2018 | 1.80 Mn |
| Jun 30, 2018 | 1.31 Mn |
| Jun 30, 2018 | 1.31 Mn |
| Mar 31, 2018 | 819,000.00 |
| Mar 31, 2018 | 819,000.00 |
| Dec 31, 2017 | 823,000.00 |
| Dec 31, 2017 | 823,000.00 |
| Sep 30, 2017 | 790,000.00 |
| Sep 30, 2017 | 790,000.00 |
| Jun 30, 2017 | 487,000.00 |
| Jun 30, 2017 | 487,000.00 |
| Mar 31, 2017 | 3.23 Mn |
| Mar 31, 2017 | 3.23 Mn |